This Article  • PDF of this Correction  • Original article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Dermatology  • Quality of Life  • Diagnosis  • Alert me on articles by topic  Social Bookmarking   What's this?

JAMA. 1999;281:325.

In the Original Contribution entitled "The Cost-effectiveness of Screening for Type 2 Diabetes" published in the November 25, 1998, issue of THE JOURNAL (1998;280:1757-1763), there was an incorrect value and a sentence was worded incorrectly. On page 1760, in the first sentence of the "Sensitivity Analyses" section, the value read "HbA_1c levels of 0.07." It should have read "HbA_1c levels of 7.0%." On page 1762, the sentence in the middle column that read "A screening program will also identify persons with impaired glucose tolerance who may benefit from early intervention, sponsored by the National Institutes of Health" should have read "A screening program will also identify persons with impaired glucose tolerance who potentially may benefit from early interventions, such as those currently being tested in the Diabetes Prevention Program (a multicenter clinical trial sponsored by the National Institutes of Health to test interventions aimed at preventing or delaying progression to diabetes among persons with impaired glucose tolerance)."

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?